Varian to collaborate with several Brazilian institutions to train healthcare professionals on radiotherapy technology

NewsGuard 100/100 Score

Varian Medical Systems (NYSE: VAR), today announced its intent to collaborate with several cancer treatment centers in Brazil for the training of healthcare professionals on advanced radiotherapy technologies. Currently the institutions in this collaborative training program will include Hospital Israelita Albert Einstein, Hospital Sirio Libanês, Beneficencia Portugesa de São Paulo, Grupo COI Rio de Janeiro and Hospital de Câncer de Barretos.

Working with these institutions, Varian will be offering training on advanced radiotherapy technologies and treatment techniques for healthcare professionals across Brazil through clinical preceptorships and schools. Participants in the preceptorships will have the opportunity to learn through in-clinic immersion sessions about treatment protocols, planning and delivery, as well as patient flow. The clinical schools will offer 2-4 day courses on select cancer treatment topics utilizing lectures and hands-on use cases from professionals at the cancer treatment center and members of Varian's clinical education and applications team.

"These collaborations provide the means for healthcare professionals in Brazil to leverage the combined expertise of leading cancer centers and Varian to increase their knowledge of radiotherapy technology and techniques to deliver a high standard of care," said Humberto Izidoro, Varian's managing director for Brazil. "We are proud to collaborate with major institutions who align with our mission to focus energy on saving lives."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Ketone supplement boosts efficacy of prostate cancer immunotherapy